Role of nitric oxide in HIV-1 infection: Friend or foe?

Lancet Infectious Diseases

Volumn 2, Issue 5, 2002, Pages 273-280

  Torre, Donato ^a   Pugliese, Agostino ^a   Speranza, Filippo ^a,b  

^a OSPEDALE DI CIRCOLO   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ANTIVIRAL ACTIVITY; APOPTOSIS; CENTRAL NERVOUS SYSTEM DISEASE; CYTOTOXICITY; DISEASE ASSOCIATION; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TH1 CELL; VIRUS REPLICATION;

EID: 0036240673     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(02)00262-1     Document Type: Review

References (69)

1. The L-arginine-nitric oxide pathway
2. Nitric oxide in inflammation and immune response
3. Nitric oxide and macrophage function
4. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
5. Regulation of biosynthesis of nitric oxide
6. Free radicals in viral pathogenesis molecular mechanisms involving superoxide and NO
7. Nitric oxide synthases: Roles, tolls, and controls
8. Simulation of the diffusion and reaction of endogenously produced nitric oxide
9. The function of nitric oxide in the immune system
10. Macrophage cytotoxicity: Role for L-arginine deiminase and iminonitrogen oxidation to nitrite
11. Nitric oxide and the immune response
12. The human immunedeficiency virus: Infectivity and mechanisms of pathogenesis
13. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection
14. Gp 120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages
15. Serum concentrations of nitrite in patients with HIV-1 infection
16. Increased levels of nitrite in the sera of children infected with human immunedeficiency virus type 1
17. Nitric oxide synthesis in patients with advanced HIV infection
18. Serum nitrite plus nitrate in infection with human immunedeficiency virus type 1
19. Increased production of nitric oxide correlates with viral load and activation of mononuclear phagocytes in HIV-infected patients
20. Production of nitric oxide from peripheral blood mononuclear cells and polymorphonuclear leukocytes of patients with HIV-1 infection
21. Does nitric oxide play a critical role in viral infections?
22. Osterhaus ADME. Inhibition of influenza virus replication by nitric oxide
23. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals
24. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite
25. Activation of HIV gene expression during monocyte differentiation by induction of NF-KB
26. In vitro antiviral activity on the replication of murine retrovirus
27. Nitric oxide modulates HIV-1 replication
28. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes implications for HIV-associated neurological disease
29. Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages
30. Nitric oxide synthesis during acute SIV mac251 infection of macaques
31. Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide
32. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway
33. Inhibitory mechanisms of antibody production by nitrogen oxides released from activated macrophages during the immune response: Relationship to energy consumption
34. Macrophage nitric oxide mediates immunosuppression in infectious inflammation
35. Immunological aspects of nitric oxide in HIV-1 infection
36. Human immunodeficiency virus and the brain
37. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
38. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia
39. Aredox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitros-compounds
40. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
41. HIV-1 coat protein neurotoxicity, mediated by nitric oxide in primary cultures
42. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp 41
43. Increased peroxynitrite activity in AIDS dementia complex: Implications for the neuropathogenesis of HIV-1 infection
44. Identification of human immunodeficiency virus type 1 tat epitope that is neuroexcitatory and neurotoxic
45. HIV-1 tat induces neuronal death via tumor necrosis factor alpha and activation of non-N-methyl-D-aspartate receptors by NFkappaB-independent mechanism
46. Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: A correlation with blood-brain-barrier dysfunction
47. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS: Molecular control and effect of highly active antiretroviral therapy
48. Induction of apoptosis by primary HIV-1 isolates correlates with productive infection in peripheral blood mononuclear cells
49. Nitric oxide: A cytotoxic activated macrophage effector molecule
50. Nitric oxide synthase induces macrophage death by apoptosis
51. Nitric oxide-mediated apoptosis in murine peritoneal macrophages
52. Nitric oxide induces apoptosis in mouse thymocytes
53. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor depriviation
54. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation
55. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels
56. Nitric oxide as a bifunctional regulator of apoptosis
57. Cytotoxicity, apoptosis, and nitric oxide
58. Critical role of nitric oxide during apoptosis of peripheral blood leukocytes from patients with AIDS
59. Nitric oxide production and apoptosis by gp 120
60. Apoptotic activity of nitric oxide in HIV-1 infected cells
61. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production
62. Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo
63. Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsachievirus B3
64. Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2)
65. Inhibitory effect of nitric oxide on the replication of a marine retrovirus in vitro and in vivo
66. An antiviral mechanism of nitric oxide: Inhibition of a viral protease
67. Cysteine nitrosylation inactivates the HIV-1 protease
68. Nitric oxide inhibits the HIV-1 reverse transcriptase activity